Cancers, Free Full-Text
Por um escritor misterioso
Descrição
As lung cancer has the highest cancer-specific mortality rates worldwide, there is an urgent need for new therapeutic and diagnostic approaches to detect early-stage tumors and to monitor their response to the therapy. In addition to the well-established tissue biopsy analysis, liquid-biopsy-based assays may evolve as an important diagnostic tool. The analysis of circulating tumor DNA (ctDNA) is the most established method, followed by other methods such as the analysis of circulating tumor cells (CTCs), microRNAs (miRNAs), and extracellular vesicles (EVs). Both PCR- and NGS-based assays are used for the mutational assessment of lung cancer, including the most frequent driver mutations. However, ctDNA analysis might also play a role in monitoring the efficacy of immunotherapy and its recent accomplishments in the landscape of state-of-the-art lung cancer therapy. Despite the promising aspects of liquid-biopsy-based assays, there are some limitations regarding their sensitivity (risk of false-negative results) and specificity (interpretation of false-positive results). Hence, further studies are needed to evaluate the usefulness of liquid biopsies for lung cancer. Liquid-biopsy-based assays might be integrated into the diagnostic guidelines for lung cancer as a tool to complement conventional tissue sampling.
Cancers, Free Full-Text
Cancer statistics, 2022 - Siegel - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
PDF) Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment
Cancers, Free Full-Text
from Flow Cytometry to Cytomics, Page 2
Cancers, Free Full-Text
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation
Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study - The Lancet Digital Health
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis - The Lancet Oncology
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
Gist Ot Typing Tool Software Free - Colaboratory
de
por adulto (o preço varia de acordo com o tamanho do grupo)
